← Leaderboards
Louis M Pelus
Indiana Univ-Purdue Univ At Indianapolis
$9,998,893
Attributed
$12,395,741
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$12,395,741 · 8
By mechanism
R01$10,310,098 · 5
T32$1,486,021 · 1
UH3$450,000 · 1
UH2$149,622 · 1
Top collaborators
- Melissa A Kacena6 shared
- Hal E. Broxmeyer5 shared
- Sherif S Farag5 shared
- Christie M Orschell5 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Hal E. Broxmeyer$36,408,829
- Christie M Orschell$7,516,916
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsCellsHematopoieticHematopoiesisDinoprostoneStem CellsTransplantationCell PhysiologyPathway InteractionsBone MarrowMarrowMaintenanceRecoveryCostCsf3 GenePeripheral BloodRadiationRegulationStromal CellsInjuryHomeostasisStressEicosanoidsPlay
Grant awards (42)
Age-Related Differences in Response to Radiation and Medical Countermeasures$131,435
UH3 · FY2020 · AI
Regulation of Hematopoietic Cell Production$516,281
T32 · FY2019 · DK
Age-Related Differences in Response to Radiation and Medical Countermeasures$148,496
UH3 · FY2019 · AI
Regulation of Hematopoietic Cell Production$494,442
T32 · FY2018 · DK
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$390,927
R01 · FY2018 · HL · contact PI
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells$319,738
R01 · FY2018 · CA
Age-Related Differences in Response to Radiation and Medical Countermeasures$170,069
UH3 · FY2018 · AI
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$390,619
R01 · FY2017 · HL · contact PI
Regulation of Hematopoietic Cell Production$381,296
T32 · FY2017 · DK
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells$321,933
R01 · FY2017 · CA
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$195,000
R01 · FY2017 · AG · contact PI
Age-Related Differences in Response to Radiation and Medical Countermeasures$97,541
UH2 · FY2017 · AI
Regulation of Hematopoietic Cell Production$888
T32 · FY2017 · DK
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$390,319
R01 · FY2016 · HL · contact PI
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells$321,933
R01 · FY2016 · CA
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$195,000
R01 · FY2016 · AG · contact PI
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$100,000
R01 · FY2016 · AG · contact PI
Regulation of Hematopoietic Cell Production$93,114
T32 · FY2016 · DK
Age-Related Differences in Response to Radiation and Medical Countermeasures$52,081
UH2 · FY2016 · AI
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$393,030
R01 · FY2015 · HL · contact PI
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells$325,817
R01 · FY2015 · CA
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$189,150
R01 · FY2015 · AG · contact PI
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$373,527
R01 · FY2014 · HL · contact PI
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells$349,482
R01 · FY2014 · CA
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$195,000
R01 · FY2014 · AG · contact PI
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$362,855
R01 · FY2013 · HL · contact PI
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$195,000
R01 · FY2013 · AG · contact PI
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$381,150
R01 · FY2012 · HL · contact PI
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$385,000
R01 · FY2011 · HL · contact PI
Role of PGE2 and other eicosanoids in hematopoietic stem cell function$385,000
R01 · FY2010 · HL · contact PI
Chemokine Induced Hematopoietic Stem Cell Mobilization$366,553
R01 · FY2009 · HL · contact PI
Chemokine Induced Hematopoietic Stem Cell Mobilization$366,553
R01 · FY2008 · HL · contact PI
Chemokine Induced Hematopoietic Stem Cell Mobilization$367,766
R01 · FY2007 · HL · contact PI
Role of Survivin in Blood Stem Cell Cycle and Apoptosis$321,078
R01 · FY2007 · HL · contact PI
Chemokine Induced Hematopoietic Stem Cell Mobilization$378,750
R01 · FY2006 · HL · contact PI
Role of Survivin in Blood Stem Cell Cycle and Apoptosis$330,668
R01 · FY2006 · HL · contact PI
Role of Survivin in Blood Stem Cell Cycle and Apoptosis$338,625
R01 · FY2005 · HL
Role of Survivin in Blood Stem Cell Cycle and Apoptosis$338,625
R01 · FY2004 · HL
Chemokine induced hematopoietic stem cell mobilization$335,250
R01 · FY2004 · HL
Chemokine induced hematopoietic stem cell mobilization$335,250
R01 · FY2003 · HL
Chemokine induced hematopoietic stem cell mobilization$335,250
R01 · FY2002 · HL
Chemokine induced hematopoietic stem cell mobilization$335,250
R01 · FY2001 · HL